Workshops are sponsored by industry and can be attended by any delegate. There is no additional charge.


MCTs & Ketones

Sponsored by The Nisshin OilliO Group, Ltd.
Monday, June 30 | 2:30 PM

The Nisshin OilliO Group is a leading oils & fats company in Japan with unparalleled technology to bring out the three powers of plants: the power to improve flavor, the power to enhance health, and the power to elevate beauty.

For many years, we have dedicated our research and development to improve the nutritional value of oils & fats and to enhance processing technology. One of the oils we have particular interest in is MCT. In recent years, we have proven the positive effects of MCTs towards malnutrition and high BMI.

We aim to contribute to people’s healthy lifespan by leveraging on lipid nutrition and processing technology.


SDA, bridging the scientific and sustainability gap between terrestrial and aquatic omega-3’s

Sponsored by Natures Crops International
Monday, June 30 | 4:30 PM

ISSFAL’s organizers wish to highlight achieving omega-3 health and wellness benefits sustainably, recognizing that the world’s oceans simply cannot provide enough omega-3 lipids to meet growing global demand. Recent research is showing how plant-based omega-3 stearidonic acid (SDA) sources, which naturally forms longer-chain PUFA efficiently in the body, can play a complementary role alongside other sources of omega-3 ALA, EPA, and DHA. Natures Crops International and Better Origins Ingredients are co-sponsoring this Special Workshop on Day 1 of the conference to underscore the unique and beneficial role that plant-based ALA/SDA sources can play in bridging sustainability and wellness benefits from omega-3’s that consumers are seeking. Each speaker has been invited to highlight research or industry perspectives and contribute to a critical discussion on factors driving broad-based shifts towards a healthful, regenerative omega-3 supply chain.

A manufacturer of specialty oils for dietary supplements, nutraceuticals, food, personal care and animal nutrition products, Natures Crops produces oils from regeneratively farmed crops by growers who follow strict management protocols for sustainability and identity preservation. Natures Crops is the exclusive worldwide grower and producer of Ahiflower® (Buglossoides arvensis) seed oil, nature’s richest source of omega-3 with the highest omega-3 SDA levels. Natures Crops ensures the crops produced are grown, processed, packaged, and delivered in a safe, sustainable, traceable, and cost-competitive manner. The company has operations in Prince Edward Island, Canada and the United Kingdom, with headquarters in North Carolina. For more information, please write to info@naturescrops.com.


Full-Fat Dairy Products, Dairy Fats and Cardiometabolic Health

Sponsored by the Dairy Research Consortium
Tuesday, 1 July | 10:00 AM

Dairy Research Consortium (DRC), a partnership among Centre National Interprofessionnel de l'Économie Laitière, Dairy Australia, Dairy Farmers of Canada, National Dairy Council, Dutch Dairy Association, and the Danish Dairy Board, to accelerate pre-competitive research on the role of dairy products in nutrition and health, promotes a widespread enhancement of knowledge in the field of dairy nutrition, thereby enabling dairy to remain a critical contributor to future sustainable food systems. DRC’s research strategy focuses on the areas of sustainable diets and food systems, dairy proteins, and the dairy matrix. Global Dairy Platform serves as the secretariat to DRC.


The Whys and Hows of Standardizing Blood Fatty Acid Analysis

Sponsored by Omegametrix
Wednesday, 2 July | 10:00 AM

Omegametrix® provides standardized analysis of 26 fatty acids in erythrocytes or whole blood, an analysis supported by and used in some 430 publications in international journals. Of course, the HS-Omega-3 Index® is a result provided, as is the HS-Trans Index®, and more to come. Omegametrix’ results have external validity, as only an analysis backed by so much scientific evidence can. Based on scientific data , the target range for the HS-Omega-3 Index has been defined to be between 8 and 11%. Because clinical effects closely correlate with the HS-Omega-3 Index, because of the complex bioavailability of EPA and DHA, and because of other issues, use of omega-3 fatty acids is only safe and effective on the basis of the HS-Omega-3 Index.